Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

267 trials with published results (11%)

Research Maturity

1248 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.8%

120 terminated out of 2488 trials

Success Rate

91.2%

+4.6% vs benchmark

Late-Stage Pipeline

5%

133 trials in Phase 3/4

Results Transparency

21%

267 of 1248 completed with results

Key Signals

267 with results91% success120 terminated

Data Visualizations

Phase Distribution

1,852Total
Not Applicable (1267)
Early P 1 (25)
P 1 (193)
P 2 (234)
P 3 (64)
P 4 (69)

Trial Status

Completed1,248
Recruiting403
Unknown403
Terminated120
Not Yet Recruiting104
Active Not Recruiting103

Trial Success Rate

91.2%

Benchmark: 86.6%

Based on 1248 completed trials

Clinical Trials (2488)

Showing 20 of 20 trials
NCT06113640Phase 2CompletedPrimary

Montelukast in Parkinson Disease

NCT06680830Phase 2RecruitingPrimary

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06582212Not ApplicableRecruiting

Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms

NCT04229056Not ApplicableActive Not RecruitingPrimary

COMPuter-assisted Self-training to Improve EXecutive Function

NCT04957095Not ApplicableRecruitingPrimary

Motor Network Physiology

NCT06285643Phase 2Active Not RecruitingPrimary

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

NCT06015841Phase 2Active Not RecruitingPrimary

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

NCT07849413Recruiting

Visual Hallucinations in Lewy Body Diseases

NCT07639463Active Not RecruitingPrimary

Upper Extremity Skills, Trunk Control, and Body Awareness in Parkinson's Disease

NCT06225830Not ApplicableCompletedPrimary

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

NCT06848192WithdrawnPrimary

The Parkinson's Disease Case-Control Study

NCT06293118Not ApplicableNot Yet RecruitingPrimary

The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease

NCT00302146CompletedPrimary

Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations

NCT01496599CompletedPrimary

Imaging Biomarkers in Parkinson s Disease

NCT06976268Phase 2RecruitingPrimary

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

NCT07843667CompletedPrimary

Pulmonary and Musculoskeletal Impairments in Parkinson's Patients

NCT06466525Phase 1RecruitingPrimary

A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.

NCT05164783Not ApplicableCompletedPrimary

Multicenter Implementation of E-monitoring in Parkinson's Disease

NCT05482126SuspendedPrimary

Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

NCT07838636Not ApplicableRecruitingPrimary

Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilateral DBS-STN Stimulation - a Randomized Controlled Trial.

Scroll to load more

Research Network

Activity Timeline